eli lilly gip/glp-1 Lilly's triple-acting obesity drug hits goal in Phase 3 trial As GLP-1 Use Expands, Long-Term

Even when your appetite decreases, the body needs time to adjust to taking in fewer calories

selection should be individualized based on indication, efficacy, tolerability, and patient-specific factors

Patients should ask about the recommended approach for their specific situation, which may include: Following a liquid-only diet for 24 hours before the procedure (in addition to the standard bowel preparation) Whether any medication adjustment is recommended based on individual risk factors What additional precautions the anesthesia team might take Diabetes management considerations are important for patients using GLP-1 agonists for glycemic control

Lipase is the primary marker to monitor

International Journal of Obesity, 37(11), 14431451

Pharmacies, hospitals, and some community cooling centers may be willing to store medication temporarily if you explain the situation